# OnCo record ross-camidge (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ross-camidge/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ross-camidge" ;
  schema:name "D. Ross Camidge"@en ;
  schema:description "Led the crizotinib and brigatinib trials that defined ALK-targeted lung cancer therapy."@en ;
  schema:url <https://onco.cc/people/ross-camidge/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Camidge%20DR%5BAuthor%5D%20ALK%20lung> ;
  onco:tag "lung", "alk", "targeted-therapy" ;
  schema:jobTitle "Joyce Zeff Chair in Lung Cancer Research, University of Colorado Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/alk/> ;
  onco:drugs <https://onco.cc/drugs/lorlatinib/> ;
  onco:institutions <https://onco.cc/institutions/colorado-cancer-center/> ;
  onco:trials <https://onco.cc/trials/crown/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-shaw-crown-lorlatinib-crizotinib-nejm-2020/> ;
  schema:affiliation <https://onco.cc/institutions/colorado-cancer-center/> .